Eskag Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.80 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.68 Cr
as on 16-11-2024
- Company Age 47 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 104.71 Cr
as on 16-11-2024
- Satisfied Charges ₹ 35.15 Cr
as on 16-11-2024
- Revenue 12.73%
(FY 2023)
- Profit 28.98%
(FY 2023)
- Ebitda 42.76%
(FY 2023)
- Net Worth 24.80%
(FY 2023)
- Total Assets 17.45%
(FY 2023)
About Eskag Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.80 Cr and a paid-up capital of Rs 1.68 Cr.
The company currently has active open charges totaling ₹104.71 Cr. The company has closed loans amounting to ₹35.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Agarwal and Sunil Agarwal serve as directors at the Company.
- CIN/LLPIN
U24234WB1977PTC030897
- Company No.
030897
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 1977
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Eskag Pharma Pvt Ltd offer?
Eskag Pharma Pvt Ltd offers a wide range of products and services, including Chemical Reagents & Catalysts, Organic Salt, Zinc salts, Printing Inks & Other Supplies, Toner Cartridges, Nutraceuticals & Dietary Supplements, Mineral Supplement, Digestive System Drugs & Medicines, Laxatives, Pharma Ingredients & Raw Materials.
Who are the key members and board of directors at Eskag Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Agarwal  | Director | 11-May-2005 | Current |
| Sunil Agarwal | Director | 13-Jun-1984 | Current |
Financial Performance and Corporate Structure Insights of Eskag Pharma.
Eskag Pharma Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 12.73% increase. The company also saw a substantial improvement in profitability, with a 28.98% increase in profit. The company's net worth Soared by an impressive increase of 24.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eskag Pharma?
In 2023, Eskag Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- West Bengal Chemical Industries Ltd.Active 36 years 7 months
Anil Agarwal and Sunil Agarwal are mutual person
Bhagirathi Commodities Private LimitedActive 17 years 2 monthsAnil Agarwal and Sunil Agarwal are mutual person
- Godavari Dealcom Private LimitedActive 16 years 8 days
Anil Agarwal and Sunil Agarwal are mutual person
- Gajalakshmi Finance Private LimitedActive 28 years 21 days
Anil Agarwal and Sunil Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 04 Jan 2023 | ₹15.00 Cr | Open |
Standard Chartered Bank Creation Date: 28 Jun 2021 | ₹17.57 Cr | Open |
Hdfc Bank Limited Creation Date: 21 Jan 2020 | ₹55.45 Cr | Open |
How Many Employees Work at Eskag Pharma?
Eskag Pharma has a workforce of 589 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eskag Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eskag Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
